地址：中国.西安曲江雁南五路曲江影视大厦六层、七层、二十五层 电话:(029)68206166 传真:(029)68206135 陕西稼轩律师事务所 关于 新疆中泰化学股份有限公司 2026 年第一次临时股东会之 法律意见书 二〇二六年二月 地址：中国.西安曲江雁南五路曲江影视大厦六层、七层、二十五层 电话:(029)68206166 传真:(029)68206135 本所律师仅就本次股东会召集、召开程序、出席会议人员资格及 表决程序的真实性、完整性、合法性、有效性发表如下法律意见： 地址：中国.西安曲江雁南五路曲江影视大厦六层、七层、二十五层 电话:(029)68206166 传真:(029)68206135 一、本次会议的召集、召开程序 （一）本次会议的召集 经查验，公司董事会于 2026 年 2 月 10 日审议通过了关于召开公 司 2026 年第一次临时股东会的议案，并在巨潮资讯网（http://www.c ninfo.com.cn）、《证券时报》公开发布了《新疆中泰化学股份有限 公司关于召开 2026 年第一次临时股东会通知的公告》（以下简称"会 议通知"），上述通知载明了本次会议的召开时间、地点、 ...

证券代码：002092 证券简称：中泰化学 公告编号：2026-012 债券代码：148437 债券简称：23新化K1 新疆中泰化学股份有限公司 2026年第一次临时股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示 新疆中泰化学股份有限公司（以下简称"公司"）于2026年2月11日在《证券 时报》和巨潮资讯网（www.cninfo.com.cn）上刊登了《新疆中泰化学股份有限 公司关于召开2026年第一次临时股东会通知的公告》。 本次股东会无否决议案的情况，无修改议案的情况，也无新议案提交表决。 一、会议召开基本情况 （一）股东会名称：2026 年第一次临时股东会 （二）会议召集人：公司董事会 （三）会议主持人：董事长黄小虎 （四）本次股东会由公司董事会提议召开，会议的召集程序符合《公司法》、 《深圳证券交易所股票上市规则》等法律、法规、规范性文件及《公司章程》的 规定。 （五）会议时间： 1、现场会议时间为：2026 年 2 月 27 日上午 12:00 （六）现场会议地点：新疆乌鲁木齐经济技术开发区阳澄湖路 39 号，电话 09 ...

（记者 张明双） 中泰化学（002092.SZ）2月25日在投资者互动平台表示，新疆中泰新材料股份有限公司资源化综合利用 制甲醇升级示范项目设计产能为100万吨/年；该项目已于2025年6月全面投产，配套余热发电装置一次 性并网发电成功，该装置通过回收甲醇生产过程中的高温余热，驱动汽轮机组发电，实现能源的梯级利 用，降低了用电成本。该项目全面投产后，有利于公司形成规模优势、产业链优势和成本优势，提升市 场竞争力。后期，公司将持续保障项目装置的安全稳定运行，强化产品质量管控与成本优化管理。 每经AI快讯，有投资者在投资者互动平台提问：请问公司甲醇项目目前详细经营销售状况，包括产能 进度，成本，销售，利润，未来预期展望等？ ...

从中泰化学十大流通股东角度 2月24日，中泰化学涨5.06%，截至发稿，报7.47元/股，成交3.58亿元，换手率1.92%，总市值193.47亿 元。 资料显示，新疆中泰化学股份有限公司位于新疆乌鲁木齐经济技术开发区阳澄湖路39号，成立日期2001 年12月18日，上市日期2006年12月8日，公司主营业务涉及聚氯乙烯树脂、离子膜烧碱等化工产品的生 产和销售。主营业务收入构成为：聚氯乙烯39.69%，氯碱类产品14.99%，粘胶纱线14.83%，其他煤化 工产品11.21%，粘胶纤维7.17%，其他纺织产品5.91%，其他(补充)3.40%，现代贸易1.35%，物流运输 1.21%，自制电0.24%。 从基金十大重仓股角度 数据显示，东证资管旗下1只基金重仓中泰化学。东方红核心价值混合A（024429）四季度持有股数420 万股，占基金净值比例为2.23%，位居第九大重仓股。根据测算，今日浮盈赚取约151.2万元。 东方红核心价值混合A（024429）成立日期2025年6月6日，最新规模4.78亿。今年以来收益7%，同类排 名2686/8994；成立以来收益18.23%。 责任编辑：小浪快报 东方红核心价值 ...

Core Viewpoint - 聚石化学 has been found guilty of engaging in fraudulent activities to inflate revenue, costs, and profits, leading to potential legal actions from investors [1][2]. Group 1: 聚石化学 - 聚石化学 and its subsidiaries inflated revenue by conducting fictitious trade activities, resulting in a reported inflated revenue of 86,550,865.69 yuan and inflated costs of 88,238,071.82 yuan, leading to a profit reduction of 1,687,206.13 yuan [1]. - The company also engaged in transactions with third-party companies that lacked commercial substance, inflating both revenue and costs by 52,236,440.86 yuan, without affecting profits [1]. - In total, for the first half of 2023, 聚石化学 inflated its operating revenue by 156,807,377.35 yuan and operating costs by 158,470,264.89 yuan, which represented 8.32% and 8.51% of total revenue and costs, respectively [2]. Group 2: 中泰化学 - 中泰化学 has also faced legal scrutiny for inflating its revenue by 4,248,474,643.06 yuan in its 2022 annual report, which accounted for 7.60% of the reported total revenue [2][3]. - The company failed to disclose significant related-party transactions involving non-operating fund occupations in its annual reports for 2021 and 2022, leading to major omissions [3]. - Investors who purchased 中泰化学 stock between April 10, 2021, and March 21, 2024, may also initiate claims due to these violations [3].

Core Viewpoint - The news highlights the administrative penalties imposed on 聚石化学 (Jushi Chemical) and 中泰化学 (Zhongtai Chemical) for engaging in fraudulent activities that inflated their financial statements, leading to potential investor claims for compensation [1][2][5]. Summary by Sections 聚石化学 (Jushi Chemical) - 聚石化学 was found to have inflated its revenue, costs, and profits through fictitious trade activities, including transactions with four companies that did not involve actual goods, resulting in a revenue inflation of approximately 86.55 million yuan and cost inflation of about 88.24 million yuan [1][2]. - The company also engaged in transactions that lacked commercial substance, inflating both revenue and costs by approximately 52.24 million yuan, without affecting profits [1][2]. - In total, for the first half of 2023, 聚石化学 inflated its operating revenue by approximately 156.81 million yuan and operating costs by about 158.47 million yuan, which represented 8.32% and 8.51% of total revenue and costs, respectively [2][5]. - Investors who purchased 聚石化学 stock between August 29, 2023, and November 22, 2025, may initiate claims for compensation due to these fraudulent activities [2][5]. 中泰化学 (Zhongtai Chemical) - 中泰化学 was found to have inflated its 2022 revenue and costs by approximately 4.25 billion yuan each, which accounted for 7.60% and 7.75% of the reported total revenue and costs in its annual report [6]. - The company failed to disclose significant related-party transactions involving non-operating fund occupations in its 2021 and 2022 annual reports, leading to major omissions [3][6]. - Investors who bought 中泰化学 stock between April 10, 2021, and March 21, 2024, are eligible to file claims for compensation due to the identified fraudulent activities [4][6].

Group 1 - The company expects a net profit loss of 230 million to 330 million yuan for the year 2025, but this represents a significant improvement compared to 2024, with a year-on-year increase of 66.21% to 76.45% [1] - The company has made impairment provisions totaling 231 million yuan, which will reduce the net profit by 196 million yuan for 2025 [1] - The improvement in performance is mainly attributed to enhanced profitability in the chlor-alkali chemical sector, improvements in the textile business, and a decrease in asset impairment losses [1] Group 2 - From February 10 to 11, 2026, the company disclosed multiple related party transactions and guarantee matters, including a guarantee fee of 5.1 million yuan paid by its subsidiary to the controlling shareholder and a new guarantee of 205 million yuan for related parties, with a total guarantee cap of 27.325 billion yuan, accounting for 125.44% of the latest net assets [2] - The stock price of the company has been active recently, with a cumulative increase of 3.42% over the past 7 days, reaching a high of 7.66 yuan, and a single-day increase of 6.18% on February 10, with a trading volume of 9.57 billion yuan [3] - Institutional sentiment is neutral, with four institutions predicting that the company will turn a profit in 2025, with a year-on-year increase of 269.54%, although current institutional research frequency is low and the fund holding ratio is only 0.25% [4]

证券日报网讯 2月12日，中泰化学在互动平台回答投资者提问时表示，公司控股子公司新疆中泰金晖能 源股份有限公司拥有大碗其钾盐矿的探矿权，目前尚未完成勘探。 （文章来源：证券日报） ...

证券日报网讯 2月12日，中泰化学在互动平台回答投资者提问时表示，公司主营业务为聚氯乙烯树脂 （PVC）、离子膜烧碱、粘胶纤维、粘胶纱四大产品，未涉及航空航天、机器人领域；具体业绩情况请 关注公司定期报告。 （文章来源：证券日报） ...

格隆汇2月12日丨中泰化学(002092.SZ)在投资者互动平台表示，公司控股子公司新疆中泰金晖能源股份 有限公司拥有大碗其钾盐矿的探矿权，目前尚未完成勘探。 ...